The results of CGP were as follows: microsatellite status: stable; tumor mutational burden: low (3.78 Muts/Mb); MYC amplification observed (absolute copy number: 59); Rb1 Splicing Variant c.1422-1G>T and TP53 c.818G>A observed. This evidence concerns the gene RB1 and neoplasm.